FDA Inspection
SRI Krishna Pharmaceuticals Ltd - Unit ISRI Krishna Pharmaceuticals Ltd - Unit I – FDA Inspection, Sep 1, 2023
Record Details
This FDA Inspection record concerns SRI Krishna Pharmaceuticals Ltd - Unit I, with an inspection on September 1, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · abc43a24-1b12-4cba-9d71-bca900b6cd7d
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1219348
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of SRI Krishna Pharmaceuticals Ltd - Unit I
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 18, 2025 | Not classified | Office of Inspections and Investigations | |
| May 15, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SRI Krishna Pharmaceuticals Ltd - Unit I
- FDA Inspection 1271116 - 2025-04-18
- FDA Inspection 928508 - 2015-05-15
- FDA Inspection 757323 - 2011-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.